1-7 of 7
Elisabetta Torlone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes: A randomized open parallel multicenter study

Geremia B. Bolli, MD, David Kerr, MD, Reena Thomas, MD, Elisabetta Torlone, MD, Agnès Sola-Gazagnes, MD, Ester Vitacolonna, MD, Jean Louis Selam, MD, Philip D. Home, DM, DPHIL
Journal: Diabetes Care
Diabetes Care 2009;32(7):1170–1176
https://doi.org/10.2337/dc08-1874
Published: 23 April 2009
View article titled, Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes: <subtitle>A randomized open parallel multicenter study</subtitle>
Open the PDF for Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes: <subtitle>A randomized open parallel multicenter study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Pharmacokinetics and Pharmacodynamics of the Long-Acting Insulin Analog Glargine After 1 Week of Use Compared With Its First Administration in Subjects With Type 1 Diabetes

Francesca Porcellati, MD, Paolo Rossetti, MD, Natalia Busciantella Ricci, MD, Simone Pampanelli, MD, Elisabetta Torlone, MD, Susana Hernandez Campos, MD, Anna Marinelli Andreoli, MD, Geremia B. Bolli, MD, Carmine G. Fanelli, MD
Journal: Diabetes Care
Diabetes Care 2007;30(5):1261–1263
https://doi.org/10.2337/dc06-2208
Published: 01 May 2007
View article titled, Pharmacokinetics and Pharmacodynamics of the Long-Acting Insulin Analog Glargine After 1 Week of Use Compared With Its First Administration in Subjects With Type 1 Diabetes
Open the PDF for Pharmacokinetics and Pharmacodynamics of the Long-Acting Insulin Analog Glargine After 1 Week of Use Compared With Its First Administration in Subjects With Type 1 Diabetes in another window
Journal Articles

Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime

Paolo Rossetti, MD, Simone Pampanelli, MD, Carmine Fanelli, MD, Francesca Porcellati, MD, Emanuela Costa, MD, Elisabetta Torlone, MD, Luciano Scionti, MD, Geremia B. Bolli, MD
Journal: Diabetes Care
Diabetes Care 2003;26(5):1490–1496
https://doi.org/10.2337/diacare.26.5.1490
Published: 01 May 2003
View article titled, Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: <subtitle>A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime </subtitle>
Open the PDF for Intensive Replacement of Basal Insulin in Patients With Type 1 Diabetes Given Rapid-Acting Insulin Analog at Mealtime: <subtitle>A 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime </subtitle> in another window
Journal Articles

Reply to Bastyr et al.

Geremia B Bolli, MD, Elisabetta Torlone, MD
Journal: Diabetes Care
Diabetes Care 1997;20(6):1048
https://doi.org/10.2337/diacare.20.6.1048a
Published: 01 June 1997
View article titled, Reply to Bastyr et al.
Open the PDF for Reply to Bastyr et al. in another window
Journal Articles

Effects of the Short-Acting Insulin Analog [Lys(B28),Pro(B29)] on Postprandial Blood Glucose Control in IDDM

Elisabetta Torlone, MD, Simone Pampanelli, MD, Carlo Lalli, MD, Paola Del Sindaco, MD, Antonio Di Vincenzo, MD, Anna Maria Rambotti, MD, Francesco Modarelli, MD, Lucilla Epifano, MD, Giorgia Kassi, MD, Gabriele Perriello, MD, Paolo Brunetti, MD, Geremia Bolli, MD
Journal: Diabetes Care
Diabetes Care 1996;19(9):945–952
https://doi.org/10.2337/diacare.19.9.945
Published: 01 September 1996
View article titled, Effects of the Short-Acting Insulin Analog [Lys(B28),Pro(B29)] on Postprandial Blood Glucose Control in IDDM
Open the PDF for Effects of the Short-Acting Insulin Analog [Lys(B28),Pro(B29)] on Postprandial Blood Glucose Control in IDDM in another window
Journal Articles

Improved Postprandial Metabolic Control After Subcutaneous Injection of a Short-Acting Insulin Analog in IDDM of Short Duration With Residual Pancreatic β-Cell Function

Simone Pampanelli, MD, Elisabetta Torlone, MD, Carlo Ialli, MD, Paola Del Sindaco, MD, Marco Ciofetta, MD, Mauro Lepore, MD, Linda Bartocci, MD, Paolo Brunetti, MD, Geremia B Bolli, MD
Journal: Diabetes Care
Diabetes Care 1995;18(11):1452–1459
https://doi.org/10.2337/diacare.18.11.1452
Published: 01 November 1995
View article titled, Improved Postprandial Metabolic Control After Subcutaneous Injection of a Short-Acting Insulin Analog in IDDM of Short Duration With Residual Pancreatic β-Cell Function
Open the PDF for Improved Postprandial Metabolic Control After Subcutaneous Injection of a Short-Acting Insulin Analog in IDDM of Short Duration With Residual Pancreatic β-Cell Function in another window
Journal Articles

Improved Insulin Action and Glycemic Control After Long Term Angiotensin-Converting Enzyme Inhibition in Subjects with Arterial Hypertension and Type II Diabetes

Elisabetta Torlone, MD, Mariella Britta, MD, Anna Maria Rambotti, MD, Gabriele Perriello, MD, Fausto Santeusanio, MD, Paolo Brunetti, MD, Geremia B Bolli, MD
Journal: Diabetes Care
Diabetes Care 1993;16(10):1347–1355
https://doi.org/10.2337/diacare.16.10.1347
Published: 01 October 1993
View article titled, Improved Insulin Action and Glycemic Control After Long Term Angiotensin-Converting Enzyme Inhibition in Subjects with Arterial Hypertension and Type II Diabetes
Open the PDF for Improved Insulin Action and Glycemic Control After Long Term Angiotensin-Converting Enzyme Inhibition in Subjects with Arterial Hypertension and Type II Diabetes in another window